Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2009 April;168(2) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2009 April;168(2):105-114

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Gazzetta Medica Italiana Archivio per le Scienze Mediche 2009 April;168(2):105-114

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Use of cytostatic and antalgic drugs for the terminal oncological patients: comparison between the years 2000 and 2004

Ghezzo F., Dell’Orco L., Racca S.

Department of Clinical and Biological Sciences S. Luigi Hospital, Orbassano, Turin, Italy


PDF


Although we cannot yet explain the reason why a person falls sick with cancer and another one does not, we know today environmental factors and characteristics of the lifestyle than can increase our probability of developing the cancer (OI, II). General term by which we define pathologies characterised by a new formation (neoplasy) of a tissue, i.e. the abnormal development of one or more cell masses increasing in an uncontrolled manner. Possible therapies are: surgery, radiotherapy, ormonal therapy, chemoterapy. Pain is one of the most common collateral effects, and the most difficult to resolve with cancer, and it is particularly intense in the terminal patient, i.e. in the cancer patient where the illness has invaded a great part of the organism, and who does not react to any therapy any more.

top of page